Diabetic type 2. It is used as monotherapy or in combination with metformin
For patients previously untreated with a hypoglycaemic agent[s] and whose HbA1c is less than or equal to 8%: Initially 0.5mg orally [max. 16mg daily]. For patients previously treated with a hypoglycaemic agent and whose HbA1c is greater than or equal to 8%: initially 1-2 mg [max. 16mg daily]. It is taken 15-30 min before meal
Mode of action
Brands containing this Ingredient
Drug Index 2.0 is hereOur new update features a more powerful search feature and easier login.
issues? Contact us
today. Contact Us
Mode of Action
A carbamolylmethyl benzoic acid derivative that acts by stimulating the release of insulin from pancreas
May cause resumption of ovulation in pre-menopausal anovulatory patients
Breastfeeding; type 1 diabetes; diabetes keto-acidosis; hepatic disorders.
Peripheral oedema; URTI; back pain; headache; anemia.